John DE Parratt

465 total citations
12 papers, 258 citations indexed

About

John DE Parratt is a scholar working on Pathology and Forensic Medicine, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John DE Parratt has authored 12 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 4 papers in Neurology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John DE Parratt's work include Multiple Sclerosis Research Studies (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Peripheral Neuropathies and Disorders (3 papers). John DE Parratt is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Peripheral Neuropathies and Disorders (3 papers). John DE Parratt collaborates with scholars based in Australia, Ireland and United Kingdom. John DE Parratt's co-authors include John W. Prineas, John D. Pollard, Michael Barnett, Robert Swingler, Raeburn B Forbes, Peter T. Donnan, Suran L. Fernando, J O’Riordan, Samuel Kwok and Martín Krause and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

John DE Parratt

10 papers receiving 252 citations

Peers

John DE Parratt
John DE Parratt
Citations per year, relative to John DE Parratt John DE Parratt (= 1×) peers Rajiv W. Jain

Countries citing papers authored by John DE Parratt

Since Specialization
Citations

This map shows the geographic impact of John DE Parratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John DE Parratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John DE Parratt more than expected).

Fields of papers citing papers by John DE Parratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John DE Parratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John DE Parratt. The network helps show where John DE Parratt may publish in the future.

Co-authorship network of co-authors of John DE Parratt

This figure shows the co-authorship network connecting the top 25 collaborators of John DE Parratt. A scholar is included among the top collaborators of John DE Parratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John DE Parratt. John DE Parratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Barnett, Michael, John DE Parratt, Con Yiannikas, et al.. (2025). Evolution of Chronic Lesion Tissue in Relapsing-Remitting Patients With Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 12(3). e200377–e200377. 2 indexed citations
2.
Krause, Martín, Georgina V. Long, Victoria Atkinson, et al.. (2023). Case series: Immune checkpoint inhibitor-induced transverse myelitis. Frontiers in Neurology. 14. 1130313–1130313. 14 indexed citations
3.
Parratt, John DE, et al.. (2021). 117 Multiple sclerosis presenting as a rapidly progressive dementia. SHILAP Revista de lepidopterología. A42.2–A42.
4.
Prineas, John W. & John DE Parratt. (2021). Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination. Journal of Neuropathology & Experimental Neurology. 80(10). 975–996. 43 indexed citations
5.
Fernando, Suran L., et al.. (2020). The Successful Use of Infliximab in a Relapsing Case of Susac’s Syndrome. SHILAP Revista de lepidopterología. 2020. 1–6. 11 indexed citations
6.
Parratt, John DE, et al.. (2018). 073 Alemtuzumab induced allergic inflammatory syndrome (ALIAS) with eosinophilic acalculous cholecystitis: a report of two cases. Journal of Neurology Neurosurgery & Psychiatry. 89(6). A30.1–A30.
7.
Parratt, John DE, et al.. (2017). Characterisation of tumefactive demyelinating lesions. Journal of Neurology Neurosurgery & Psychiatry. 88(5). e1.9–e1. 2 indexed citations
8.
Blair, Nicholas, John DE Parratt, Roger Garsia, David Brazier, & Phillip D. Cremer. (2013). Inflammatory trigeminal nerve and tract lesions associated with inferior alveolar nerve anaesthesia. Journal of Clinical Neuroscience. 20(11). 1608–1610. 3 indexed citations
9.
Prineas, John W. & John DE Parratt. (2012). Oligodendrocytes and the early multiple sclerosis lesion. Annals of Neurology. 72(1). 18–31. 124 indexed citations
10.
Femia, Giuseppe, John DE Parratt, & G. Michael Halmagyi. (2012). Isolated reversible hypoglossal nerve palsy as the initial manifestation of pre-eclampsia. Journal of Clinical Neuroscience. 19(4). 602–603. 2 indexed citations
11.
Barnett, Michael, John DE Parratt, John D. Pollard, & John W. Prineas. (2009). MS: is it one disease?. PubMed. 16(2). 57–65. 31 indexed citations
12.
Donnan, Peter T., et al.. (2005). Multiple sclerosis in Tayside, Scotland: detection of clusters using a spatial scan statistic. Multiple Sclerosis Journal. 11(4). 403–408. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026